Common Contracts
8 similar Loan Agreement contracts by Windtree Therapeutics Inc /De/
Loan AgreementLoan Agreement • October 28th, 2019 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of October 24, 2019, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH II Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • December 7th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of December 5, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH II Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • November 23rd, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of November 19, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • October 25th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of October 19, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • October 3rd, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of September 27, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • September 14th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of September 12, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • August 29th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of August 29, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
Loan AgreementLoan Agreement • August 20th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of August 14, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
